Riboxinum ampoules - when cells requires "first aid"
Riboxinum ampoules administered intravenously.Most often this treatment is required in acute conditions such as acute cardiac arrhythmias.Riboxin in this case, the faster and more intensively.But, like any other drug, the main mechanism of action is the effect on metabolism improves metabolism and losing weight without dieting , efficiency Riboxin appears after treatment.
Action Riboxin ampoules on various human organs
Riboxinum (active substance - inosine) is a stimulator of metabolic processes in cells and is available in different dosage forms, including a 2% solution in ampoules of 10ml.A solution for intravenous administration.
Entering directly into the bloodstream, Riboxinum quickly reaches the tissues sensitive to it.Since their structure is Riboxinum nucleoside (a substance that normally found in the cells of various tissues and is a precursor to ATP), it's easy, "as a home", penetrates the cell, charging them with energy and activates all types of metabolism.As a result, the cell rapidly revived, to become less vulnerable to the negative effects.
particular sensitivity to Riboxinum shows myocardium - cardiac muscle.The fact that this muscle never rests, its cells require continuous and uninterrupted supply of nutrients and oxygen.If it does not, then there is first a strong pain in my heart pain in the heart - always consult a physician , and then myocardial cells die.So proceeds coronary heart disease (CHD), when the coronary arteries become clogged with atherosclerotic plaque, reduces their clearance.Riboksina solution introduced into the vein, in this case, can improve myocardial cells and condition of the patient as a whole.
In acute liver disease, kidney disease, glaucoma Riboxinum also administered intravenously.
Riboxinum ampoules with severe cardiovascular diseases
Myocardial infarction - a necrosis (necrosis) of the heart muscle cells that develops in violation of patency of coronary arteries.With timely provision of such medical care to the patient at the site of necrosis develops scar connective tissue and the heart continues.Introduction Riboxin after myocardial infarction promotes faster during the recovery period, the formation of scar and restore the normal functioning myocardial cells located around the necrosis.Such cells are usually affected, but not killed, and their timely recovery is very important for the whole body.
myocardial infarction Riboxinum injected into a vein slowly jet, but more often it is done by drip.For intravenous drip Riboxinum diluted with 250 ml of 0.9% sodium chloride solution (saline) or 5% glucose Glucose: The energy source .The introduction begins with 200 mg (10% solution 2 ml) once a day.If the patient tolerates Riboxinum, the dose increased to 40 mg (20 ml of a 2% solution) twice a day.The course of treatment usually lasts from 10 days to two weeks.After that, if necessary, pass on prescription pills on Riboxin.
Sometimes Riboxinum jet injected into a vein slowly, for example, against the background of the sudden onset of an attack of arrhythmia.Thus it is very slow and controlled condition of the patient is administered 10 to 20 ml of a 2% solution of Riboxin (200 to 400 mg).
Riboxinum in capsules for the treatment of other serious diseases
Riboxinum ampoules administered as acute hepatitis.Typically, in this case Riboxinum vnutrivnno introduced dropwise at a rate of 40-60 drops per minute.This creates a fast introduction of energy feeding the liver cells, and increase their resistance to infection.In severe chronic hepatitis occurring when progressively reduced liver function, treatment Riboxin also begin with his intravenous drip, and after a two-week course of therapy switching to pills.
Sometimes intravenous Riboxin required to prevent serious violations of blood supply to the kidneys, which could lead to necrosis of kidney tissue.Such circulatory disorders often develop against kidney surgery or trauma of the body.To prevent such complications Riboxinum usually administered intravenously, the number of infusions determined by a physician and depends on the patient's condition.
In some cases, intravenous administration is contraindicated Riboxin
Intravenous Riboxin contraindicated in severe renal disease with a significant decrease in their function, gout, pregnancy, breast- Breastfeeding - a personal choice breast-aged18 and hypersensitive to the components of the drug.
intravenous drip Riboxin generally well tolerated, but sometimes patients begin attacks of tachycardia, requiring dose reduction or discontinuation of therapy.There may be an allergic reaction to the drug.